A prospective evaluation of haemodynamics, functional status, and quality of life after radiofrequency catheter ablation of long-standing persistent atrial fibrillation

Europace

Volumn 16, Issue 1, 2014, Pages 15-25

  Fiala, Martin ^a,b   Wichterle, Dan ^c,d   Bulková, Veronika ^a,d   Škňouřil, Libor ^a   Nevřalová, Renáta ^a   Toman, Ondřej ^b   Dorda, Miloslav ^a   Januška, Jaroslav ^a   Špinar, Jindřich ^b  

^a Hospital Podlesí a s   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^c INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Atrial fibrillation; Catheter ablation; Long standing persistent; Outcome

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; HORMONE PRECURSOR;

ADULT; AGED; ARTICLE; CATHETER ABLATION; CONTROLLED STUDY; EXERCISE TEST; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SINUS RHYTHM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VERY ELDERLY;

ATRIAL FIBRILLATION; CATHETER ABLATION; LONG-STANDING PERSISTENT; OUTCOME;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; ATRIAL FIBRILLATION; CATHETER ABLATION; CHRONIC DISEASE; DEPRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; QUALITY OF LIFE; RECOVERY OF FUNCTION; TREATMENT OUTCOME;

EID: 84891361126     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut161     Document Type: Article

References (34)

1. Häissaguerre M, Sanders P, Hocini M, Takahashi Y, Rotter M, Sacher F et al. Catheter ablationof long-lasting persistent atrialfibrillation: critical structures for termination. J Cardiovasc Electrophysiol 2005;16:1125-37.
2. Häissaguerre M, Hocini M, Sanders P, Sacher F, Rotter M, Takahashi Y et al. Catheter ablation of long-lasting atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias. J Cardiovasc Electrophysiol 2005;16:1138-47.
3. Rostock T, Steven D, Hoffmann BA, Servatius H, Drewitz I, Sydow K et al. Chronic atrial fibrillation is a biatrial arrhythmia: data from catheter ablation of chronic atrial fibrillation aiming arrhythmia termination using a sequential ablation approach. Circ Arrhythm Electrophysiol 2008;1:344-53.
4. Fiala M, Chovanćik J, Wojnarová D, Bulková V, Szymeczek H, Nevralová R et al. Results of complex left atrial ablation of long-lasting persistent atrial fibrillation. J Interv Card Electrophysiol 2008;23:189-98.
5. Rostock T, Drewitz I, Steven D, Hoffmann BA, Salukhe TV, Bock K et al. Characterization, mapping, and catheter ablation of recurrent atrial tachycardia after stepwise ablation of long-lasting persistent atrial fibrillation. Circ Arrhythm Electrophysiol 1010; 3:160-9.
6. Natale A, Leonelli F, Beheiry S, Newby K, Pisano E, Potenza D et al. Catheter ablation approach on the right side only for paroxysmal atrial fibrillation therapy: long-tem results. Pacing Clin Electrophysiol 2000;23:224-33.
7. Greiner W, Weijnen T, Nieuwenhuizen M, Oppe S, Badia X, Busschbach J et al. A single European currency for EQ-5D health states. Results from a six country study. Eur J Health Econ 2003;4:222-31.
8. Müller H, Noble S, Keller PF, Sigaud P, Gentil P, Lerch R et al. Biatrial anatomical reverse remodeling after radiofrequency catheter ablation for atrial fibrillation: evidence from real-time three-dimensional echocardiography. Europace 2008;10: 1073-8.
9. Hof IE, Velthuis BK, Chaldoupi SM, Wittkampf FH, van Driel VJ, van der Heijden JF et al. Pulmonary vein antrum isolation leads to a significant decrease of the left atrial size. Europace 2011;13:371-5.
10. Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996;61:755-9.
11. Goldman ME, Pearce LA, Hart RG, Zabalgoitia M, Asinger RW, Safford R et al. Patho-physiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study). J Am Soc Echocardiogr 1999;12:1080-7.
12. Oral H, Chugh A, Özaydin M, Good E, Fortino J, Sankaran S et al. Risk of thrombo-embolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation 2006;114:759-65.
13. Nademanee K, Schwab MC, Kosar EM, Karwecki M, Moran MD, Visessook N et al. Clinical outcomes of catheter ablation for high-risk patients with atrial fibrillation. J Am Coll Cardiol 2008;51:843-9.
14. Themistoclakis S, Corrado A, Marchlinski FE, Jäis P, Zado E, Rossillo A et al. The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation. J Am Coll Cardiol 2010;55:735-43.
15. Feinberg MS, Waggoner AD, Kater KM, Cox JL, Lindsay BD, Perez JE et al. Restoration of atrial function after the maze procedure for patients with atrial fibrillation: assessment by Doppler echocardiography. Circulation 1994;90:II285-92.
16. Yuda S, Nakatani S, Kosakai Y, Yamagishi M, Miyatake K. Long-term follow-upofatrial contraction after the maze procedure in patients with mitral valve disease. J Am Coll Cardiol 2001;37:1622-7.
17. Bauer EP, Szalay ZA, Brandt RR, Pitschner HF, Bachmann G, Brunner-La Rocca HP et al. Predictors for atrial transport function after mini-maze operation. Ann Thorac Surg 2001;72:1251-4.
18. Isobe F, Kumano H, Ishikawa T, Sasaki Y, Kinugasa S, Nagamachi K et al. A new procedure for chronic atrial fibrillation: bilateral appendage-preserving maze procedure. Ann Thorac Surg 2001;72:1473-8.
19. Takahashi Y, O'Neill MD, Hocini M, Reant P, Jönsson A, Jäis P et al. Effects of stepwise ablation of chronic atrial fibrillation on atrial electrical and mechanical properties. J Am Coll Cardiol 2007;49:1306-14.
20. Donal E, Yamada H, Leclerq C, Herpin D. The left atrial appendage, a small blind structure: a review of its echocardiographic evaluation and its critical role. Chest 2005;128:1853-62.
21. Fatkin D, Feneley MP. Patterns of Doppler-measured blood flow velocity in the normal and fibrillating human left atrial appendage. Am Heart J 1996;132:995-1003.
22. Jue J, Winslow T, Fazio G, Redberg RF, Foster E, Schiller NB. Pulsed Doppler characterization of left atrial appendage flow. J Am Soc Echocardiogr 1993;6:237-44.
23. Tabata T, Oki T, Fukuda N, Iuchi A, Manabe K, Kageji Yet al. Influence of aging on left atrial appendage flow velocity patterns in normal subjects. J Am Soc Echocardiogr 1996;9:274-80.
24. Muellerleile K, Sultan A, Groth M, Steven D, Hoffmann B, Adam G et al. Velocity encoded cardiovascular magnetic resonance to assess left atrial appendage emptying. J Cardiovasc Magn Reson 2011;14:39-46.
25. Sacher F, Corcuff JB, Schraub P, Le Bouffos V, Georges A, Jones SO et al. Chronic atrial fibrillation ablation impact on endocrine and mechanical cardiac functions. Eur Heart J 2008;29:1290-5.
26. De Potter T, Berruezo A, Mont L, Matiello M, Tamborero D, Santibanez C et al. Left ventricular systolic dysfunction by itself does not influence outcome of atrial fibrillation ablation. Europace 2010;12:24-9.
27. Shelton RJ, Clark AL, Goode K, Rigby AS, Cleland JG. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation. Eur Heart J 2006;27:2353-61.
28. Danicek V, Theodorovich N, Bar-Chaim S, Miller A, Vered Z, Koren-Morag N et al. Sinus rhythm restoration after atrial fibrillation: the clinical value of N-terminal pro-BNP measurements. Pacing Clin Electrophysiol 2008;31:955-60.
29. Govindan M, Borgulya G, Kiotsekoglou A, Saha SK, Camm AJ. Prognostic value of left atrial expansion index and exercise-induced change in atrial natriuretic peptide as long-term predictors of atrial fibrillation recurrence. Europace 2012;14: 1302-10.
30. Kallergis EM, Manios EG, Kanoupakis EM, Mavrakis HE, Goudis CA, Maliaraki NE et al. Effect of sinus rhythm restoration after electrical cardioversion on apelin and brain natriuretic peptide prohormone levels in patients with persistent atrial fibrillation. Am J Cardiol 2010;105:90-4.
31. Yamada T, Murakami Y, Okada T, Yoshida N, Toyama J, Yoshida Y et al. Plasma brain natriuretic peptide level after radiofrequency catheter ablation of paroxysmal, persistent, and permanent atrial fibrillation. Europace 2007;9:770-4.
32. Jais P, Cauchemez B, Macle LR, Daoud E, Khairy P, Subbiah R et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 2008;118: 2498-505.
33. Wokhlu A, Monahan KH, Hodge DO, Asirvatham SJ, Friedman PA, Munger TM et al. Long-term quality of life after ablation of atrial fibrillation: the impact of recurrence, symptom relief, and placebo effect. J Am Coll Cardiol 2010;55:2309-16.
34. Quercioli C, Mesina G, Barbini E, Carriero G, Fani M, Nante N. Importance ofsocio-demographic and morbidity aspects in measuring health-related quality of life: performance of three tools. Eur J Health Econ 2009;10:389-97.